MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Correlation between striatal CIT uptake and Mini-Mental State Examination in Parkinson’s disease

    OD. Kwon, SG. Park, SB. Lee, JA. Park (Daegu, Republic of Korea)

    Objective: This study was performed to identify any relationship between the amount of decline of receptor uptake of CIT and Mini-Mental State Examination(MMSE) score in…
  • 2019 International Congress

    DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead

    C. Nombela, A. Lozano, C. Villanueva-Iza, J. Barcia (Madrid, Spain)

    Objective: The study proposed a new Deep Brain Stimulation (DBS) approach in Parkinson´s disease (PD): the Globus pallidus pars interna (GPi) + Nucleus Basalis of…
  • 2019 International Congress

    Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

    V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)

    Objective: The study aimed to examine the neurocognitive changes following STN-DBS in patients with PD. Background: Neurocognitive evaluation is a standard procedure preoperatively in patients…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • 2019 International Congress

    Increased hub function in posterior medial cortex in Parkinson’s disease without mild cognitive impairement – A resting state fMRI study –

    A. Nagano-Saito, P. Bellec, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, J. Lissemore, K. Smart, C. Benkelfat, O. Monchi (Montreal, QC, Canada)

    Objective: Using resting-state functional MRI (rsfMRI) data of younger and older healthy volunteers and patients with Parkinson’s disease (PD) with and without mild cognitive impairment…
  • 2019 International Congress

    Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction

    M. Rakhimova, N. Yusupova (Tashkent, Uzbekistan)

    Objective: This study examined the relationships of mobility, motor and cognitive function measures at baseline, and of mobility and cognitive measures over four years Background:…
  • 2019 International Congress

    Neuropathological findings in a SPG4 gene mutation carrier

    S. Forcén, I. Aldecoa, AM. Crespo, O. Ramos, L. Ispierto, R. álvarez, D. Vilas (Badalona, Spain)

    Objective: To describe the clinical and neuropathological findings of a patient carrier of a mutation in the SPG4 gene. Background: Hereditary spastic paraplegia (HSP) linked…
  • 2019 International Congress

    Influence of peripheral immune system on cognitive profile in Parkinson’s disease

    L. Magistrelli, E. Storelli, V. Milner, E. Rasini, F. Marino, M. Cosentino, C. Comi (Varese, Italy)

    Objective: To investigate the influence of the peripheral immune profile in the development of cognitive impairment in PD. Background: Dementia is frequent in advanced Parkinson’s…
  • 2019 International Congress

    Correlation of P300 parameters with cognition and impulse control disorders in patients with idiopathic Parkinson’s disease

    R. Kandadai, R. Annakula, S. Sarva, S. Meka, T. Syed, S. Tandra, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To evaluate prevalence of impulse control disorders in patients with Parkinson's disease(PD), assess P300 latencies and look for any correlation between P300 latencies and…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in Parkinson’s disease

    A. Amara, K. Wood, A. Joop, R. Memon, J. Pilkington, M. Bamman, C. Hurt (Birmingham, AL, USA)

    Objective: Investigate relationship between cognitive performance and mobility in persons with Parkinson’s disease (PD). Background: Persons with PD experience both motor and non-motor symptoms. Two…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley